Pingkui Enema Alleviates TNBS-Induced Ulcerative Colitis by Regulation of Inflammatory Factors, Gut Bifidobacterium, and Intestinal Mucosal Barrier in Rats

被引:12
作者
Yun, Hai-Feng [1 ]
Liu, Rui [1 ]
Han, Dan [1 ]
Zhao, Xin [1 ]
Guo, Jin-Wei [1 ]
Yan, Feng-Jiao [1 ]
Zhang, Chuan [1 ]
Sun, Hong-Wen [1 ]
Liang, Guo-Qiang [2 ]
Zhang, Guo-Xing [3 ]
机构
[1] Nanjing Univ Chinese Med, Suzhou Tradit Chinese Med Hosp, Dept Internal Med, 18 Yang Su Rd, Suzhou 215003, Peoples R China
[2] Nanjing Univ Chinese Med, Suzhou Tradit Chinese Med Hosp, Suzhou Acad Wumen Chinese Med, 18 Yang Su Rd, Suzhou 215003, Peoples R China
[3] Soochow Univ, Med Coll, Dept Physiol, 199 Ren Ai Rd,Dushu Lake Campus,Suzhou Ind Pk, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
TRADITIONAL CHINESE MEDICINE; BOWEL-DISEASE; ESCHERICHIA-COLI; MICROBIOTA; THERAPY; INTERLEUKIN-13; EPIDEMIOLOGY; PROBIOTICS; EFFICACY; FORMULA;
D O I
10.1155/2020/3896948
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Ulcerative colitis (UC) is a chronic recurrent inflammation of the colon, and clinical outcome of UC is still unsatisfied. Pingkui enema, a traditional Chinese medicine prescription, has been safely applied for the treatment of diarrhea and dysentery in clinic for many years. However, its mechanism is still elusive. The present study is designed to investigate the effect of Pingkui enema on trinitrobenzene sulfonic acid- (TNBS-) induced ulcerative colitis (UC) and possible mechanism in rats.Methods. UC was induced by intracolonic instillation of TNBS in male Sprague-Dawley rats, which were treated with different dosages of Pingkui enema (low, medium, and high) or sulfasalazine for ten days. Survival rate was calculated. A clinical disease activity score was evaluated. Histological colitis severity was analyzed by hematoxylin-eosin (HE) staining. Content of Bifidobacterium in intestinal tissue was analyzed by RT-PCR. Concentration of IL-8, IL-13, TNF-alpha,D-lactic acid (D-LA), and diamine oxidase (DAO) in serum and contents of adhesin and receptor of Bifidobacterium adhesion in rat intestinal mucus were measured by ELISA.Results. The results showed that Pingkui enema treatment with high dosage markedly improved the survival rate compared with untreated and sulfasalazine treated groups. All dosages of Pingkui enema reduced pathological score. High dosage of Pingkui enema and sulfasalazine treatments significantly reduced the serum concentration of IL-8, TNF-alpha,D-LA, and DAO and markedly increased the serum concentration of IL-13. In addition, high-dose Pingkui enema and sulfasalazine treatments increased gut content of Bifidobacterium, gut mucus expressions of adhesin, and adhesin receptor of Bifidobacterium.Conclusions. Pingkui enema has therapeutic effect on TNBS-induced UC, and possible mechanism may be via regulation of gut probiotics (Bifidobacterium) and inflammatory factors and protection of intestinal mucosal barrier.
引用
收藏
页数:10
相关论文
共 42 条
  • [1] The Intestinal Microbiota in Inflammatory Bowel Disease
    Becker, Christoph
    Neurath, Markus F.
    Wirtz, Stefan
    [J]. ILAR JOURNAL, 2015, 56 (02) : 192 - 204
  • [2] Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
    Berg, Dana
    Clemente, Jose C.
    Colombel, Jean-Frederic
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (06) : 781 - 795
  • [3] Absence of a role for interleukin-13 in inflammatory bowel disease
    Biancheri, Paolo
    Di Sabatino, Antonio
    Ammoscato, Francesca
    Facciotti, Federica
    Caprioli, Flavio
    Curciarello, Renata
    Hoque, Syed S.
    Ghanbari, Amir
    Joe-Njoku, Ijeoma
    Giuffrida, Paolo
    Rovedatti, Laura
    Geginat, Jens
    Corazza, Gino R.
    MacDonald, Thomas T.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (02) : 370 - 385
  • [4] The epidemiology of inflammatory bowel disease
    Burisch, Johan
    Munkholm, Pia
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (08) : 942 - 951
  • [5] HYDROPHOBIC ADHESIN OF ESCHERICHIA-COLI IN ULCERATIVE-COLITIS
    BURKE, DA
    AXON, ATR
    [J]. GUT, 1988, 29 (01) : 41 - 43
  • [6] Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases
    Cammarota, Giovanni
    Pecere, Silvia
    Laniro, Gianluca
    Masucci, Luca
    Curro, Diego
    [J]. DIGESTIVE DISEASES, 2016, 34 (03) : 279 - 285
  • [7] Effects of berberine on intracellular free calcium in smooth muscle cells of guinea pig colon
    Cao, JW
    Luo, HS
    Yu, BP
    Huang, XD
    Sheng, ZX
    Yu, JP
    [J]. DIGESTION, 2001, 64 (03) : 179 - 183
  • [8] Progress in active compounds effective on ulcerative colitis from Chinese medicines
    Cao Si-Yu
    Ye Sheng-Jie
    Wang Wei-Wei
    Wang Bing
    Zhang Tong
    Pu Yi-Qiong
    [J]. CHINESE JOURNAL OF NATURAL MEDICINES, 2019, 17 (02) : 81 - 102
  • [9] Inhibition of lipopolysaccharide and interferon-gamma-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by Lithospermi radix in mouse peritoneal macrophages
    Chung, HS
    Kang, M
    Cho, CW
    Park, S
    Kim, H
    Yoon, YS
    Kang, J
    Shin, MK
    Hong, MC
    Bae, H
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2005, 102 (03) : 412 - 417
  • [10] New therapies for inflammatory bowel disease: from the bench to the bedside
    Danese, Silvio
    [J]. GUT, 2012, 61 (06) : 918 - 932